These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12696627)

  • 1. Anti-E alloimmunization in pregnancy: management dilemmas.
    To WW; Ho SN; Mok KM
    J Obstet Gynaecol Res; 2003 Feb; 29(1):45-8. PubMed ID: 12696627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient.
    Judd WJ; Luban NL; Ness PM; Silberstein LE; Stroup M; Widmann FK
    Transfusion; 1990 Feb; 30(2):175-83. PubMed ID: 2154871
    [No Abstract]   [Full Text] [Related]  

  • 4. ABO haemolytic disease of the newborn: laboratory prediction and post-natal diagnosis.
    Lockyer WJ
    Med Lab Sci; 1982 Jul; 39(3):287-95. PubMed ID: 6752621
    [No Abstract]   [Full Text] [Related]  

  • 5. [New possibilities in diagnosis of hemolytic diseases in newborns].
    Fischer K; Poschmann A; Grundmann A; Asmussen S
    Infusionsther Transfusionsmed; 1992 Aug; 19(4):208-13. PubMed ID: 1422082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of maternal anti-D concentrations during pregnancy.
    Filbey D; Berseus O; Sandström B; Wesström G
    Early Hum Dev; 1987 Jan; 15(1):1-9. PubMed ID: 3102209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systematic detection of anti-erythrocyte alloimmunization during pregnancy. Experience at the Lyon Regional Blood Transfusion Center].
    Moncharmont P; Juron-Dupraz F; Vignal M; Rigal D
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(3):321-4. PubMed ID: 2500475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother.
    Wang M; Hays T; Ambruso DR; Silliman CC; Dickey WC
    Pediatr Blood Cancer; 2005 Nov; 45(6):861-2. PubMed ID: 16007582
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohaematological aspects of modern prenatal, maternal and newborn care.
    Neubauer G; Joó-Szabados T; Kovács E; Székessy V; Wohlmuth G
    Ann Immunol Hung; 1972; 16(0):277-82. PubMed ID: 4213173
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant fetal anemia and thrombocytopenia due to anti-D and anti-HPA1a alloimmunization.
    Carbonne B; Chéreau E; Larsen M; Kaplan C; Brossard Y
    Prenat Diagn; 2005 Dec; 25(12):1172-4. PubMed ID: 16315336
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemolytic disease.
    Freda V
    Clin Obstet Gynecol; 1973 Mar; 16(1):72-102. PubMed ID: 4196840
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
    Fischer K
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of pregnancy complicated by Rh-immunization. Review with respect to own investigations and results.
    Bartsch FK
    Pathologica; 1972; 64(929):139-48. PubMed ID: 4210413
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohematologic aspects of alloimmunization and alloantibody detection: A focus on pregnancy and hemolytic disease of the fetus and newborn.
    Gupta GK; Balbuena-Merle R; Hendrickson JE; Tormey CA
    Transfus Apher Sci; 2020 Oct; 59(5):102946. PubMed ID: 32962917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience.
    Moncharmont P; Juron Dupraz F; Vignal M; Rigal D; Meyer F; Debeaux P
    Arch Gynecol Obstet; 1991; 248(4):175-80. PubMed ID: 1910321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 20. [The importance of unusual isoimmunizations in the prophylaxis of hemolytic disease of the newborn].
    Joó-Szabados T; Neubauer G; Székessy V; Wohlmuth G
    Acta Paediatr Acad Sci Hung; 1970; 11(2):111-4. PubMed ID: 5504582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.